Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of CJ-50300 Smallpox Vaccine in Healthy Volunteers
NCT00607243Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2008
- Primary completion
- Jun 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Smallpox Vaccine MRC-5 in smallpox, sponsored by Seoul National University Hospital. Started Jan 2008; status: completed.
02
Drugs
Smallpox Vaccine MRC-5
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00607243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607243.